We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Kodiak Sciences Inc is is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. Kodiak Sciences Inc is is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases.
Kodiak Sciences to Participate in Upcoming Investor Conferences PR Newswire PALO ALTO, Calif., Nov. 11, 2024 PALO ALTO, Calif., Nov. 11, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a...
Kodiak Sciences to Present at Innovate Retina 2024 PR Newswire PALO ALTO, Calif., Oct. 14, 2024 PALO ALTO, Calif., Oct. 14, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a...
Kodiak Sciences to Host Investor R&D Day Today at 10:30am Eastern Time PR Newswire NEW YORK, Sept. 23, 2024 NEW YORK, Sept. 23, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), will...
Kodiak Sciences to Host Investor R&D Day on September 23, 2024 in New York City PR Newswire PALO ALTO, Calif., Sept. 17, 2024 PALO ALTO, Calif., Sept. 17, 2024 /PRNewswire/ -- Kodiak Sciences...
Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2024 Financial Results PR Newswire PALO ALTO, Calif., Aug. 14, 2024 PALO ALTO, Calif., Aug. 14, 2024 /PRNewswire/ -- Kodiak...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.23 | 31.6195372751 | 3.89 | 5.39 | 3.89 | 479357 | 4.82841153 | CS |
4 | 2.23 | 77.1626297578 | 2.89 | 5.39 | 2.8 | 360277 | 4.03195827 | CS |
12 | 2.5 | 95.4198473282 | 2.62 | 5.39 | 2.29 | 224397 | 3.38869831 | CS |
26 | 1.5 | 41.4364640884 | 3.62 | 5.39 | 2.185 | 265755 | 3.07392554 | CS |
52 | 3.53 | 222.012578616 | 1.59 | 7.77 | 1.59 | 521242 | 3.97308444 | CS |
156 | -107.77 | -95.4646115688 | 112.89 | 112.89 | 1.37 | 704321 | 9.31148142 | CS |
260 | -18.19 | -78.0351780352 | 23.31 | 171.21 | 1.37 | 565009 | 28.10390907 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions